New Results on Treatment of Supportive Therapies - European Cancer Congress (ESMO) 2023

New Results for Treatment of Head and Neck Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Colon Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Non-Metastatic Stomach Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Early Breast Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Metastatic Breast Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Rectal Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Metastatic Stomach Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Colorectal Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Melanoma - European Cancer Congress (ESMO) 2023Подробнее

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2Подробнее

New Results on Treatment of Early Lung Cancer - European Cancer Congress (ESMO) 2023Подробнее